Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'RIFAMPICIN' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 470 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Equi, A; Redington, A; Rosenthal, M; Taylor, GM; Jaswon, M; Bush, A
      Pulmonary artery occlusion from tuberculous lymphadenopathy in a child

      PEDIATRIC PULMONOLOGY
    2. Gennaro, MC; Calvino, R; Abrigo, C
      Ion interaction reagent reversed-phase high-performance liquid chromatography determination of anti-tuberculosis drugs and metabolites in biological fluids

      JOURNAL OF CHROMATOGRAPHY B
    3. Caviglia, HA; Fernandez-Palazzi, F; Galatro, G; Perez-Bianco, R
      Chemical synoviorthesis with rifampicin in haemophilia

      HAEMOPHILIA
    4. Liu, XG; Li, RC
      Effects of repeated rifabutin administration on the pharmacokinetics of intravenous and oral ciprofloxacin in mice

      JOURNAL OF CHEMOTHERAPY
    5. Almeida, FCL; Amorim, GC; Moreau, VH; Sousa, VO; Creazola, AT; Americo, TA; Pais, APN; Leite, A; Netto, LES; Giordano, RJ; Valente, AP
      Selectively labeling the heterologous protein in Escherichia coli for NMR studies: A strategy to speed up NMR spectroscopy

      JOURNAL OF MAGNETIC RESONANCE
    6. Burman, WJ; Jones, BE
      Treatment of HIV-related tuberculosis in the era of effective antiretroviral therapy

      AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
    7. Pillai, G; Ellard, GA; Smith, PJ; Fourie, PB
      The potential use of urinary excretion data for assessing the relative bioavailability of rifampicin in fixed dose combination anti-tuberculosis formulations

      INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
    8. van Loenhout-Rooyackers, JH; Keyser, A; Laheij, RJF; Verbeek, ALM; van der Meer, JWM
      Tuberculous meningitis: is a 6-month treatment regimen sufficient?

      INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
    9. Albert, H; Heydenrych, A; Mole, R; Trollip, A; Blumberg, L
      Evaluation of FASTPlaqueTB-RIF (TM), a rapid, manual test for the determination of rifampicin resistance from Mycobacterium tuberculosis cultures

      INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
    10. Narayanan, PR
      Low rate of emergence of drug resistance in sputum positive patients treated with short course chemotherapy

      INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
    11. Pargal, A; Rani, S
      Non-linear pharmacokinetics of rifampicin in healthy Asian Indian volunteers

      INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
    12. Dye, C; Espinal, MA
      Will tuberculosis become resistant to all antibiotics?

      PROCEEDINGS OF THE ROYAL SOCIETY OF LONDON SERIES B-BIOLOGICAL SCIENCES
    13. Zhang, J; Kuehl, P; Green, ED; Touchman, JW; Watkins, PB; Daly, A; Hall, SD; Maurel, P; Relling, M; Brimer, C; Yasuda, K; Wrighton, SA; Hancock, M; Kim, RB; Strom, S; Thummel, K; Russell, CG; Hudson, JR; Schuetz, EG; Boguski, MS
      The human pregnane X receptor: genomic structure and identification and functional characterization of natural allelic variants

      PHARMACOGENETICS
    14. Mercadante, S; Villari, P; Fulfaro, F
      Rifampicin in opioid-induced itching

      SUPPORTIVE CARE IN CANCER
    15. Konig, DP; Schierholz, JM; Munnich, U; Rutt, J
      Treatment of staphylococcal implant infection with rifampicin-ciprofloxacin in stable implants

      ARCHIVES OF ORTHOPAEDIC AND TRAUMA SURGERY
    16. Dutt, M; Khuller, GK
      Liposomes and PLG microparticles as sustained release antitubercular drug carriers - an in vitro-in vivo study

      INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
    17. Gomez-Lus, R; Adrian, F; del Campo, R; Gomez-Lus, P; Sanchez, S; Garcia, C; Rubio, MC
      Comparative in vitro bacteriostatic and bactericidal activity of trovafloxacin, levofloxacin and moxifloxacin against clinical and environmental isolates of Legionella spp.

      INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
    18. Norton, RE; Patole, S; Whitehall, J
      An in vitro study of the efficacy of rifampicin and minocycline coated umbilical venous catheters

      INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
    19. Dhople, AM
      In vitro activity of KRM-1648, either singly or in combination with ofloxacin, against Mycobacterium ulcerans

      INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
    20. Park, JH; Lee, KB; Kwon, IC; Bae, YH
      PDMS-based polyurethanes with MPEG grafts: Mechanical properties, bacterial repellency, and release behavior of rifampicin

      JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
    21. Orisakwe, OE; Afonne, OJ; Agbasi, PU; Ilondu, NA; Ofoefule, SI; Obi, E
      Adsorptive capacity of activated charcoal for rifampicin with and without sodium chloride and sodium citrate

      BIOLOGICAL & PHARMACEUTICAL BULLETIN
    22. de Fijter, CWH; ter Wee, PM; Oe, LP; Verbrugh, HA
      Intraperitoneal ciprofloxacin and rifampicin versus cephradine as initial treatment of (C)APD-related peritonitis: A prospective randomized multicenter comparison (CIPPER Trial)

      PERITONEAL DIALYSIS INTERNATIONAL
    23. Rind, FMA; Khuhawar, MY; Rajper, AD
      HPLC determination of phenylpropanolamine in pharmaceutical preparations using 4-dimethylaminobenzaldehyde as a derivatizing reagent

      JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
    24. Suarez, S; O'Hara, P; Kazantseva, M; Newcomer, CE; Hopfer, R; McMurray, DN; Hickey, AJ
      Respirable PLGA microspheres containing rifampicin for the treatment of tuberculosis: Screening in an infectious disease model

      PHARMACEUTICAL RESEARCH
    25. Sharma, R; Saxena, D; Dwivedi, AK; Misra, A
      Inhalable microparticles containing drug combinations to target alveolar macrophages for treatment of pulmonary tuberculosis

      PHARMACEUTICAL RESEARCH
    26. Rao, BS; Seshasayana, A; Saradhi, SVP; Kumar, NR; Narayan, CPS; Murthy, KVR
      Correlation of 'in vitro' release and 'in vivo' absorption characteristicsof rifampicin from ethylcellulose coated nonpareil beads

      INTERNATIONAL JOURNAL OF PHARMACEUTICS
    27. Singh, S; Mariappan, TT; Sankar, R; Sarda, N; Singh, B
      A critical review of the probable reasons for the poor/variable bioavailability of rifampicin from anti-tubercular fixed-dose combination (FDC) products, and the likely solutions to the problem

      INTERNATIONAL JOURNAL OF PHARMACEUTICS
    28. Shishoo, CJ; Shah, SA; Rathod, IS; Savale, SS; Vora, MJ
      Impaired bioavailability of rifampicin in presence of isoniazid from fixeddose combination (FDC) formulation

      INTERNATIONAL JOURNAL OF PHARMACEUTICS
    29. Kwon, HJ; Park, KY; Kim, SJ; Yoo, HS
      Application of nucleotide sequence of RNA polymerase beta-subunit gene (rpoB) to molecular differentiation of serovars of Salmonella enterica subsp enterica

      VETERINARY MICROBIOLOGY
    30. Doan, NT; Stewart, PR; Smith, GD
      Inhibition of bacterial RNA polymerase by the cyanobacterial metabolites 12-epi-hapalindole E isonitrile and calothrixin A

      FEMS MICROBIOLOGY LETTERS
    31. Tambe, SM; Sampath, L; Modak, SM
      In vitro evaluation of the risk of developing bacterial resistance to antiseptics and antibiotics used in medical devices

      Journal of antimicrobial chemotherapy
    32. Johnson, JL; Okwera, A; Hom, DL; Mayanja, H; Kityo, CM; Nsubuga, P; Nakibali, JG; Loughlin, AM; Yun, H; Mugyenyi, PN; Vernon, A; Mugerwa, RD; Ellner, JJ; Whalen, CC
      Duration of efficacy of treatment of latent tuberculosis infection in HIV infected adults

      AIDS
    33. Hahn, Y; Shin, S
      Electrochemical behavior and differential pulse polarographic determination of rifampicin in the pharmaceutical preparations

      ARCHIVES OF PHARMACAL RESEARCH
    34. Ortiz, A; Barat, A; Oliva, H
      Rifampicin induced acute renal failure

      NEFROLOGIA
    35. Hadama, A; Ieiri, I; Morita, T; Kimura, M; Urae, A; Irie, S; Kaneda, T; Mamiya, K; Tashiro, N; Higuchi, S; Otsubo, K
      P-hydroxylation of phenobarbital: Relationship to (s)-mephenytoin hydroxylation (CYP2C19) polymorphism

      THERAPEUTIC DRUG MONITORING
    36. Bottger, EC
      Drug-resistant tuberculosis

      LANCET
    37. Bothamley, G
      Drug treatment for tuberculosis during pregnancy - Safety considerations

      DRUG SAFETY
    38. Strauss, RM; Green, ST; Gawkrodger, DJ
      Rifampicin allergy confirmed by an intradermal test, but with a negative patch test

      CONTACT DERMATITIS
    39. Miche, L; Balandreau, J
      Effects of rice seed surface sterilization with hypochlorite on inoculatedBurkholderia vietnamiensis

      APPLIED AND ENVIRONMENTAL MICROBIOLOGY
    40. Mani, C; Selvakumar, N; Narayanan, S; Narayanan, PR
      Mutations in the rpoB gene of multidrug-resistant Mycobacterium tuberculosis clinical isolates from India

      JOURNAL OF CLINICAL MICROBIOLOGY
    41. Drancourt, M; Carlioz, A; Raoult, D
      rpoB sequence analysis of cultured Tropheryma whippelii

      JOURNAL OF CLINICAL MICROBIOLOGY
    42. Inglis, AML; Miller, AK; Culkin, KT; Finnerty, D; Patterson, SD; Jorkasky, DK; Freed, MI
      Lack of effect of rosiglitazone on the pharmacokinetics of oral contraceptives in healthy female volunteers

      JOURNAL OF CLINICAL PHARMACOLOGY
    43. de Miranda, SS; Kritski, A; Filliol, I; Mabilat, C; Panteix, G; Drouet, E
      Mutations in the rpoB gene of rifampicin-resistant Mycobacterium tuberculosis strains isolated in Brazil and France

      MEMORIAS DO INSTITUTO OSWALDO CRUZ
    44. Maeda, S; Matsuoka, M; Nakata, N; Kai, M; Maeda, Y; Hashimoto, K; Kimura, H; Kobayashi, K; Kashiwabara, Y
      Multidrug resistant Mycobacterium leprae from patients with leprosy

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    45. Koseoglu, F; Emiroglu, R; Karakayali, H; Bilgin, N; Haberal, M
      Prevalence of mycobacterial infection in solid organ transplant recipients

      TRANSPLANTATION PROCEEDINGS
    46. Jenkins, PA; Banks, J; Campbell, IA; Prescott, RJ; Smith, AP
      First randomised trial of treatments for pulmonary disease caused by M avium intracellulare, M malmoense, and M xenopi in HIV negative patients: rifampicin, ethambutol and isoniazid versus rifampicin and ethambutol

      THORAX
    47. Song, ZH; Lu, JH; Zhao, TZ
      Chemiluminescence sensor for isoniazid with controlled-reagent-release technology

      TALANTA
    48. Tapsall, J; Shultz, T; Limnios, E; Munro, R; Mercer, J; Porritt, R; Griffith, J; Hogg, G; Lum, G; Lawrence, A; Hansman, D; Collignon, P; Southwell, P; Ott, K; Gardam, M; Richardson, CJL; Bates, J; Murphy, D; Smith, H
      Surveillance of antibiotic resistance in invasive isolates of Neisseria meningitidis in Australia 1994-1999

      PATHOLOGY
    49. Dickinson, BD; Altman, RD; Nielsen, NH; Sterling, ML
      Drug interactions between oral contraceptives and antibiotics

      OBSTETRICS AND GYNECOLOGY
    50. Rossolillo, P; Albertini, AM
      Functional analysis of the Bacillus subtilis yshD gene, a mutS paralogue

      MOLECULAR AND GENERAL GENETICS
    51. Harroun, TA; Bradshaw, JP; Ashley, RH
      Inhibitors can arrest the membrane activity of human islet amyloid polypeptide independently of amyloid formation

      FEBS LETTERS
    52. Soini, H; Musser, JM
      Molecular diagnosis of mycobacteria

      CLINICAL CHEMISTRY
    53. Yew, WW
      Therapeutic drug monitoring in antituberculosis chemotherapy: clinical perspectives

      CLINICA CHIMICA ACTA
    54. Zhou, HH
      CYP2C19 genotype determines enzyme activity and inducibility of S-mephenytoin hydroxylase

      CLINICA CHIMICA ACTA
    55. Kyokawa, Y; Nishibe, Y; Wakabayashi, M; Harauchi, T; Maruyama, T; Baba, T; Ohno, K
      Induction of intestinal cytochrome P450 (CYP3A) by rifampicin in beagle dogs

      CHEMICO-BIOLOGICAL INTERACTIONS
    56. Shehatta, I; Kenawy, I; Askalany, A; Hassan, A
      Thermodynamic of metal complexation of the macrocyclic antibiotic rifampicin

      CANADIAN JOURNAL OF CHEMISTRY-REVUE CANADIENNE DE CHIMIE
    57. Hakkola, J; Raunio, H; Purkunen, R; Saarikoski, S; Vahakangas, K; Pelkonen, O; Edwards, RJ; Boobis, AR; Pasanen, M
      Cytochrome P450 3A expression in the human fetal liver: Evidence that CYP3A5 is expressed in only a limited number of fetal livers

      BIOLOGY OF THE NEONATE
    58. Bertilsson, G; Berkenstam, A; Blomquist, P
      Functionally conserved xenobiotic responsive enhancer in cytochrome P450 3A7

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    59. Malik, R; Martin, P; Wigney, D; Swan, D; Sattler, PS; Cibilic, D; Allen, J; Mitchell, DH; Chen, SCA; Hughes, MS; Love, DN
      Treatment of canine leproid granuloma syndrome: preliminary findings in seven dogs

      AUSTRALIAN VETERINARY JOURNAL
    60. Kalpana, T; Karunakar, N; Reddy, MS; Prabhakar, MC; Krishna, DR
      Assessment of antioxidant activity of some antileprotic drugs

      ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH
    61. Dhople, AM
      In vivo susceptibility of Mycobacterium ulcerans to KRM-1648, a new benzoxazinorifamycin, in comparison with rifampicin - Anti-mycobacterial activityof KRM-1648

      ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH
    62. Lomillo, MAA; Renedo, OD; Martinez, MJA
      Resolution of ternary mixtures of rifampicin, isoniazid and pyrazinamide by differential pulse polarography and partial least squares method

      ANALYTICA CHIMICA ACTA
    63. Espinosa-Mansilla, A; Valenzuela, MIA; de la Pena, AM; Salinas, F; Canada, FC
      Comparative study of partial least squares and a modification of hybrid linear analysis calibration in the simultaneous spectrophotometric determination of rifampicin, pyrazinamide and isoniazid

      ANALYTICA CHIMICA ACTA
    64. Ingham, CJ; Furneaux, PA
      Mutations in the beta subunit of the Bacillus subtilis RNA polymerase thatconfer both rifampicin resistance and hypersensitivity to NusG

      MICROBIOLOGY-UK
    65. Castro, JL; Rabago, LR; Vello, R; Perez, MD; Redondo, M; Blesa, C; Diaz, B
      Acute pancreatitis induced by rifampicin.

      REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS
    66. Narita, M; Stambaugh, JJ; Hollender, ES; Jones, D; Pitchenik, AE; Ashkin, D
      Use of rifabutin with protease inhibitors for human immunodeficiency virus-infected patients with tuberculosis

      CLINICAL INFECTIOUS DISEASES
    67. Mitchison, DA
      Role of individual drugs in the chemotherapy of tuberculosis

      INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
    68. Zwolska, Z; Augustynowicz-Kopec, E; Klatt, M
      Primary and acquired drug resistance in Polish tuberculosis patients: results of a study of the national drug resistance surveillance programme

      INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
    69. Traore, H; Fissette, K; Bastian, I; Devleeschouwer, M; Portaels, F
      Detection of rifampicin resistance in Mycobacterium tuberculosis isolates from diverse countries by a commercial line probe assay as an initial indicator of multidrug resistance

      INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
    70. Ohno, M; Yamaguchi, I; Yamamoto, I; Fukuda, T; Yokota, S; Maekura, R; Ito, M; Yamamoto, Y; Ogura, T; Maeda, K; Komuta, K; Igarashi, T; Azuma, J
      Slow N-acetyltransferase 2 genotype affects the incidence of isoniazid andrifampicin-induced hepatotoxicity

      INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
    71. Cook, SV; Fujiwara, PI; Frieden, TR
      Rates and risk factors for discontinuation of rifampicin

      INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
    72. Johnson, JL; Okwera, A; Nsubuga, P; Nakibali, JG; Whalen, CC; Hom, D; Cave, MD; Yang, ZH; Mugerwa, RD; Ellner, JJ
      Efficacy of an unsupervised 8-month rifampicin-containing regimen for the treatment of pulmonary tuberculosis in HIV-infected adults

      INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
    73. McNerney, R; Kiepiela, P; Bishop, KS; Nye, PM; Stoker, NG
      Rapid screening of Mycobacterium tuberculosis for susceptibility to rifampicin and streptomycin

      INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
    74. Kiepiela, P; Bishop, KS; Smith, AN; Roux, L; York, DF
      Genomic mutations in the katG, inhA and aphC genes are useful for the prediction of isoniazid resistance in Mycobacterium tuberculosis isolates from Kwazulu Natal, South Africa

      TUBERCLE AND LUNG DISEASE
    75. Attri, S; Rana, SV; Vaiphei, K; Sodhi, CP; Katyal, R; Goel, RC; Nain, CK; Singh, K
      Isoniazid- and rifampicin-induced oxidative hepatic injury - protection byN-acetylcysteine

      HUMAN & EXPERIMENTAL TOXICOLOGY
    76. Nakamoto, T; Hase, I; Imaoka, S; Hiroi, T; Oda, Y; Asada, A; Funae, Y
      Quantitative RT-PCR for CYP3A4 mRNA in human peripheral lymphocytes: induction of CYP3A4 in lymphocytes and in liver by rifampicin

      PHARMACOGENETICS
    77. Samuelsson, S; Hansen, ET; Osler, M; Jeune, B
      Prevention of secondary cases of meningococcal disease in Denmark

      EPIDEMIOLOGY AND INFECTION
    78. Nakajima, A; Yajima, S; Shirakura, T; Ito, T; Kataoka, Y; Ueda, K; Nagoshi, D; Kanemoto, H; Matsuhashi, N
      Rifampicin-associated pseudomembranous colitis

      JOURNAL OF GASTROENTEROLOGY
    79. Kohno, K; Mizuta, Y; Yoshida, T; Watanabe, H; Nishida, H; Fukami, K; Iida, S; Haramaki, R; Wada, Y; Tamai, O; Tamaki, K; Kato, S; Morimatsu, M; Okuda, S
      Minimal change nephrotic syndrome associated with rifampicin treatment

      NEPHROLOGY DIALYSIS TRANSPLANTATION
    80. Becquemont, L; Camus, M; Eschwege, V; Barbu, V; Rey, E; Funck-Brentano, C; Jaillon, P
      Lymphocyte P-glycoprotein expression and activity before and after rifampicin in man

      FUNDAMENTAL & CLINICAL PHARMACOLOGY
    81. O'Hara, P; Hickey, AJ
      Respirable PLGA microspheres containing rifampicin for the treatment of tuberculosis: Manufacture and characterization

      PHARMACEUTICAL RESEARCH
    82. Vicaretti, M; Hawthorne, W; Ao, PY; Fletcher, JP
      Does in situ replacement of a staphylococcal infected vascular graft with a rifampicin impregnated gelatin sealed Dacron graft reduce the incidence of subsequent infection?

      INTERNATIONAL ANGIOLOGY
    83. Panchagnula, R; Kaur, KJ; Singh, I; Kaul, CL
      Bioequivalence of rifampicin when administered as a fixed-dose combined formulation of four drugs versus separate formulations

      METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY
    84. Dabbs, ER; Quan, S
      Light inhibits rifampicin inactivation and reduces rifampicin resistance due to a cloned mycobacterial ADP-ribosylation gene

      FEMS MICROBIOLOGY LETTERS
    85. Henwood, SQ; de Villiers, MM; Liebenberg, W; Lotter, AP
      Solubility and dissolution properties of generic rifampicin raw materials

      DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
    86. Rao, BS; Murthy, KVR
      Preparation and in vitro evaluation of chitosan matrices cross-linked by formaldehyde vapors

      DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
    87. Niemi, M; Kivisto, KT; Backman, JT; Neuvonen, PJ
      Effect of rifampicin on the pharmacokinetics and pharmacodynamics of glimepiride

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    88. Zhang, W; Jiang, X; Hu, J; Fu, C
      Rifampicin polylactic acid microspheres for lung targeting

      JOURNAL OF MICROENCAPSULATION
    89. Sonnenberg, P; Silber, E; Ho, KC; Koornhof, HJ
      Meningococcal disease in South African goldmines - Epidemiology and strategies for control

      SOUTH AFRICAN MEDICAL JOURNAL
    90. Takeda, K; Watanabe, J; Inoue, K; Kanamura, S
      Rifampicin suppresses hepatic CYP2E1 expression and minimizes DNA injury caused by carbon tetrachloride in perivenular hepatocytes of mice

      ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
    91. Liu, YP; Behr, MA; Small, PM; Kurn, N
      Genotypic determination of Mycobacterium tuberculosis antibiotic resistance using a novel mutation detection method, the branch migration inhibition M-tuberculosis antibiotic resistance test

      JOURNAL OF CLINICAL MICROBIOLOGY
    92. Hart, CA
      Infectious diseases: meningococcal disease

      WESTERN JOURNAL OF MEDICINE
    93. Heep, M; Odenbreit, S; Beck, D; Decker, J; Prohaska, E; Rieger, U; Lehn, N
      Mutations at four distinct regions of the rpoB gene can reduce the susceptibility of Helicobacter pylori to rifamycins

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    94. Heep, M; Rieger, U; Beck, D; Lehn, N
      Mutations in the beginning of the rpoB gene can induce resistance to rifamycins in both Helicobacter pylori and Mycobacterium tuberculosis

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    95. Maurin, M; Mersali, NF; Raoult, D
      Bactericidal activities of antibiotics against intracellular Francisella tularensis

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    96. Pfyffer, GE
      Drug-resistant tuberculosis: resistance mechanisms and rapid susceptibility testing

      SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT
    97. Mamiya, K; Hadama, A; Yukawa, E; Ieiri, I; Otsubo, K; Ninomiya, H; Tashiro, N; Higuchi, S
      CYP2C19 polymorphism effect on phenobarbitone - Pharmacokineties in Japanese patients with epilepsy: analysis by population pharmacokinetics

      EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
    98. Hartmann, A; Halvorsen, CE; Jenssen, T; Bjorneklett, A; Brekke, IB; Bakke, SJ; Hirschberg, H; Tonjum, T; Gaustad, P
      Intracerebral abscess caused by Nocardia otitidiscaviarum in a renal transplant patient-cured by evacuation plus antibiotic therapy

      NEPHRON
    99. Golyasnaya, NV; Tyurina, NA
      Culture age of Escherichia coli and the frequency of mutations induced by N-methyl-N '-nitro-N-nitrosoguanidine

      MICROBIOLOGY
    100. DeMasi, J; Traktman, P
      Clustered charge-to-alanine mutagenesis of the vaccinia virus H5 gene: Isolation of a dominant, temperature-sensitive mutant with a profound defect in morphogenesis

      JOURNAL OF VIROLOGY


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 20/10/20 alle ore 02:33:47